Form 10-Q VISHAY INTERTECHNOLOGY For: Oct 03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 3, 2026
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
... (continue reading...)
Form 8-K Riot Platforms, Inc. For: Oct 29
0001167419false00011674192026-10-292026-10-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 29, 2026
Riot Platforms, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-33675
84-1553387
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S.... (continue reading...)
Form 8-K WESTLAKE CORP For: Nov 04
false0001262823NYSETX00012628232026-11-042026-11-040001262823exch:XNYSus-gaap:CommonStockMember2026-11-042026-11-040001262823exch:XCHIus-gaap:CommonStockMember2026-11-042026-11-040001262823wlk:OnePointSixTwoFivePercentageSeniorNotesDueTwentyTwentyNineMemberDomain2026-11-042026-11-04UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) ofthe Securities Exchange Act of 1934Date of Report (date of... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Westlake Chemical Partne For: Nov 04
-
Form 6-K JD.com, Inc. For: Nov 04
-
Form 10-Q Rapport Therapeutics, For: Sep 30
-
Form 8-K Polar Power, Inc. For: Nov 04
-
Form 8-K Tronox Holdings plc For: Nov 03
-
Form 10-Q Viridian Therapeutics, For: Sep 30
-
Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 04
-
Form 6-K dLocal Ltd For: Nov 04
-
Form 4 Seaport Therapeutics, For: Nov 03 Filed by: Torres Denice
-
Form 6-K Itau Unibanco Holding For: Nov 03
-
Form 10-Q uniQure N.V. For: Sep 30
-
Form 4 Estrella Immunopharma, For: Nov 02 Filed by: Pussinen Cynthia
-
Form 8-K NATURAL RESOURCE PARTNER For: Nov 04
-
Form 8-K CS Disco, Inc. For: Nov 04
-
Form 8-K VISHAY INTERTECHNOLOGY For: Nov 04
-
Form 10-Q Shoals Technologies Grou For: Sep 30
-
Form 6-K GLOBALFOUNDRIES Inc. For: Sep 30
-
Form 8-K Array Technologies, Inc. For: Nov 04
-
Form 8-K Kyndryl Holdings, Inc. For: Nov 04
-
Form 10-Q Odyssey Therapeutics, For: Sep 30
-
Form 10-Q Q32 Bio Inc. For: Sep 30
-
Form 8-K Dine Brands Global, Inc. For: Nov 04
-
Form 10-Q LIFECORE BIOMEDICAL, For: Sep 30
-
Form 8-K SelectQuote, Inc. For: Nov 04
-
Form 8-K LIFECORE BIOMEDICAL, For: Nov 04
-
Form 6-K Brookfield Renewable For: Sep 30
-
Form 10-Q FISERV INC For: Sep 30
-
Form 8-K GERON CORP For: Nov 04
-
Form 8-K Rapport Therapeutics, For: Nov 04
-
Form 8-K Datadog, Inc. For: Nov 04
-
Form 8-K Viridian Therapeutics, For: Nov 04
-
Form 10-Q MoonLake Immunotherapeut For: Sep 30
-
Form 6-K Itau Unibanco Holding For: Nov 03
-
Form 8-K uniQure N.V. For: Nov 04
-
Form 8-K Shoals Technologies Grou For: Nov 04
-
Form 10-Q Pharmaceutical Resource For: Sep 30
-
Form 6-K GLOBALFOUNDRIES Inc. For: Sep 30
-
Form 6-K Brookfield Renewable For: Sep 30
-
Form 144 Luckin Coffee Inc. Filed by: An Jing
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 10-Q RYTHM, Inc. For: Sep 30
-
Form 8-K Worksport Ltd For: Nov 04
-
Form 8-K CDW Corp For: Nov 04
-
Form 8-K MoonLake Immunotherapeut For: Nov 04
-
Form 6-K ATS Corp /ATS For: Sep 27
-
Form 8-K Nuvectis Pharma, Inc. For: Nov 04
-
Form 10-Q CPI Card Group Inc. For: Sep 30
-
Form 8-K RYTHM, Inc. For: Nov 04
-
Form 8-K Criteo S.A. For: Nov 04
-
Form 8-K Seres Therapeutics, Inc. For: Nov 04


